SK Bioscience Co Ltd Cash Flow Quality Index
SK Bioscience Co Ltd cash flow quality index. SK Bioscience Co Ltd (302440) has a Cash Flow Quality Index of 0.84x as of September 2025. Operating cash flow of ₩20.65 Billion is below net income of ₩24.48 Billion, suggesting accrual-heavy earnings not yet converted to cash. See SK Bioscience Co Ltd financial flexibility index to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of SK Bioscience Co Ltd (2018–2023)
Cash flow quality index of SK Bioscience Co Ltd from 2018 to 2023. Historical Cash Flow Quality Index for SK Bioscience Co Ltd across 6 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore 302440 debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
SK Bioscience Co Ltd Cash Flow Quality Index by Year (2018–2023)
SK Bioscience Co Ltd cash flow quality index by year from 2018 to 2023. Year-by-year earnings quality comparison for SK Bioscience Co Ltd. For the full cash flow conversion analysis, see 302440 operating cash flow.
| Year | Quality Index | Operating CF (KRW) | Net Income | YoY Change |
|---|---|---|---|---|
| 2023 | 1.31x | ₩29.35 Billion | ₩22.32 Billion | ▲ +228.9% |
| 2022 | -1.02x | ₩-124.96 Billion | ₩122.45 Billion | ▼ -167.5% |
| 2021 | 1.51x | ₩536.59 Billion | ₩355.14 Billion | ▼ -58.7% |
| 2020 | 3.66x | ₩120.22 Billion | ₩32.89 Billion | ▲ +200.0% |
| 2019 | 1.22x | ₩21.82 Billion | ₩17.91 Billion | ▼ -96.6% |
| 2018 | 35.41x | ₩14.90 Billion | ₩420.84 Million | — |